ECP-105

N/A

Report date: 2024/08/09 10:36:06

Base Information

Drug NameECP-105
Drug Alias NameECP-105
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsFibrosisGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanogenics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanogenics Ltd
Inactive CompaniesN/A
Active IndicationsFibrosisGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A